A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)

Clinical trial NCT00753415 · COMPLETED

Trial details

NCT number: NCT00753415
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Small Cell Lung Carcinoma Breast Cancer Melanoma Upper GI Tract Carcinoma Colon Carcinoma Renal Cell Carcinoma Bladder Carcinoma Prostate Cancer

Start date: 2008-08-01
Primary completion: 2011-04-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.